Current Neuro-Oncology

Volume 23 Number 8
30 April 2021

Home > Publications > Current Neuro-Oncology > Volume 23, Year 2021 > Number 8, 30 April


Kochanowski P, Catapano J, Pudełek M, Wróbel T, Madeja Z, Ryszawy D, Czyż J.
Temozolomide Induces the Acquisition of Invasive Phenotype by O6-Methylguanine-DNA Methyltransferase (MGMT)+ Glioblastoma Cells in a Snail-1/Cx43-Dependent Manner.
Int J Mol Sci. 2021 Apr 16, 2021;22(8):4150
. doi: 10.3390/ijms22084150. PMID: 33923767. Laboratory investigation. ˍ

Pérez JPM, Muchart J, López VS, Capella MS, Salvador N, Jaume SP, Martínez OC, La Madrid AM.
Targeted therapy for pediatric low-grade glioma.
Childs Nerv Syst. 2021 Apr 17
. doi: 10.1007/s00381-021-05138-3. PMID: 33864514. Observational study. ˍ

Kotecha R, Tonse R, Appel H, Odia Y, Kotecha RR, Rabinowits G, Mehta MP.
Regression of Intracranial Meningiomas Following Treatment with Cabozantinib.
Curr Oncol. 2021 Apr 18, 2021;28(2):1537-1543
. doi: 10.3390/curroncol28020145. PMID: 33919580. Case report. ˍ

Suwala AK, Stichel D, Schrimpf D, Maas SLN, Sill M, Dohmen H, Banan R, Reinhardt A, Sievers P, Hinz F, Blattner-Johnson M, Hartmann C, Schweizer L, Boldt HB, Kristensen BW, Schittenhelm J, Wood MD, Chotard G, Bjergvig R, Das A, Tabori U, Hasselblatt M, Korshunov A, Abdullaev Z, Quezado M, Aldape K, Harter PN, Snuderl M, Hench J, Frank S, Acker T, Brandner S, Winkler F, Wesseling P, Pfister SM, Reuss DE, Wick W, von Deimling A, Jones DTW, Sahm F.
Glioblastomas with primitive neuronal component harbor a distinct methylation and copy-number profile with inactivation of TP53, PTEN, and RB1.
Acta Neuropathol. 2021 Apr 19
. doi: 10.1007/s00401-021-02302-6. PMID: 33876327. Laboratory investigation. ˍ

Li M, Ren X, Dong G, Wang J, Jiang H, Yang C, Zhao X, Zhu Q, Cui Y, Yu K, Lin S.
Distinguishing Pseudoprogression From True Early Progression in Isocitrate Dehydrogenase Wild-Type Glioblastoma by Interrogating Clinical, Radiological, and Molecular Features.
Front Oncol. 2021 Apr 20, 2021;11:627325
. doi: 10.3389/fonc.2021.627325. PMID: 33959496. Observational study. ˍ

Pasqualini C, Rubino J, Brard C, Cassard L, André N, Rondof W, Scoazec JY, Marchais A, Nebchi S, Boselli L, Grivel J, Aerts I, Thebaud E, Paoletti X, Minard-Colin V, Vassal G, Geoerger B.
Phase II and biomarker study of programmed cell death protein 1 inhibitor nivolumab and metronomic cyclophosphamide in paediatric relapsed/refractory solid tumours: Arm G of AcSé-ESMART, a trial of the European Innovative Therapies for Children With Cancer Consortium.
Eur J Cancer. 2021 Apr 20, 2021;150:53-62
. doi: 10.1016/j.ejca.2021.03.032. PMID: 33892407. Interventional study. ˍ

Dono A, Mitra S, Shah M, Takayasu T, Zhu JJ, Tandon N, Patel CB, Esquenazi Y, Ballester LY.
PTEN mutations predict benefit from tumor treating fields (TTFields) therapy in patients with recurrent glioblastoma.
J Neurooncol. 2021 Apr 21
. doi: 10.1007/s11060-021-03755-1. PMID: 33881725. Observational study. ˍ

Song J, Aljabab S, Abduljabbar L, Tseng YD, Rockhill JK, Fink JR, Chang L, Halasz LM.
Radiation-induced brain injury in patients with meningioma treated with proton or photon therapy.
J Neurooncol. 2021 Apr 22
. doi: 10.1007/s11060-021-03758-y. PMID: 33886111. Observational study. ˍ

Zheng H, Li J, Liu H, Wu C, Gui T, Liu M, Zhang Y, Duan S, Li Y, Wang D.
Clinical-MRI radiomics enables the prediction of preoperative cerebral spinal fluid dissemination in children with medulloblastoma.
World J Surg Oncol. 2021 Apr 22, 2021;19(1):134
. doi: 10.1186/s12957-021-02239-w. PMID: 33888125. Observational study. ˍ


Bender K, Perez E, Chirica M, Onken J, Kahn J, Brenner W, Ehret F, Euskirchen P, Koch A, Capper D, Kaul D.
High-grade astrocytoma with piloid features (HGAP): the Charité experience with a new central nervous system tumor entity.
J Neurooncol. 2021 Apr 27
. doi: 10.1007/s11060-021-03749-z. PMID: 33905054. Case series. ˍ

Gao F, Zhao W, Li M, Ren X, Jiang H, Cui Y, Lin S.
Role of circulating tumor cell detection in differentiating tumor recurrence from treatment necrosis of brain gliomas.
Biosci Trends. 2021 Apr 29, 2021;15(2):107-117
. doi: 10.5582/bst.2021.01017. PMID: 33952802. Observational study. ˍ

Kurdi M, Shafique Butt N, Baeesa S, Alghamdi B, Maghrabi Y, Bardeesi A, Saeedi R, Al-Sinani T, Alghanmi N, Bari MO, Samkari A, Lary AI.
The Impact of IDH1 Mutation and MGMT Promoter Methylation on Recurrence-Free Interval in Glioblastoma Patients Treated With Radiotherapy and Chemotherapeutic Agents.
Pathol Oncol Res. 2021 Apr 29, 2021;27:1609778
. doi: 10.3389/pore.2021.1609778. PMID: 34257620. Observational study. ˍ

Abousaud M, Faroqui NM, Lesser G, Strowd RE, Ramkissoon SH, Kwatra M, Houston KS, Hsu FC, Carter A, Petro R, DeTroye AT.
Clinical Experience using Osimertinib in Patients with Recurrent Malignant Gliomas Containing EGFR Alterations.
J Cancer Sci Clin Ther. 2021 Apr 29, 2021;5(2):210-220
. doi: 10.26502/jcsct.5079114. PMID: 35601813. Observational study. ˍ

Maurer CJ, Mader I, Joachimski F, Staszewski O, Märkl B, Urbach H, Roelz R.
Do gliosarcomas have distinct imaging features on routine MRI?
Neuroradiol J. 2021 Apr 30,
2021;34(5):501-508. doi: 10.1177/19714009211012345. PMID: 33928823. Observational study. ˍ

Prado RMA, Tamura BP, Gomez GD.
Optic pathway gliosarcoma: A very rare location for a rare disease.
Radiol Case Rep. 2021 Apr 30, 2021;16(7):1665-1668
. doi: 10.1016/j.radcr.2021.04.001. PMID: 34007379. Case report. ˍ